Katherine Shanahan is Senior Pharmacy Analytic Advisor at Truven by Merative, where she helps commercial and government payers, providers, and researchers to develop and deliver actionable pharmacy-related analytics. She supports customer efforts to identify cost-saving opportunities and healthcare quality improvement strategies through improved medication management and prescribing.
The rise of metabolic gene therapies represents a critical juncture for benefits management. These treatments offer genuine hope for patients with serious conditions, but they also pose significant financial challenges.